Neurogene Inc (NGNE) stock news · $286.5M cap
Neurogene Inc (NGNE) is a biotechnology company listed on US.
This NGNE news page leads with what Neurogene Inc filed — not a scraped headline mill.
No cached 8-K sentence for NGNE yet. We will not pad this page with generic market recap.
Latest reported NGNE revenue for 2025-12-31 was $0. Net income was -$90.4M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. NGNE currently screens at market cap $286.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NGNE stock page; for the tape open the quote page.
NGNE stock news FAQ
What is NGNE's latest net income?
Latest cached Neurogene Inc (NGNE) net income was -$90.4M. Statements: https://lician.com/financials/ngne
What is NGNE's market cap?
Neurogene Inc (NGNE) market cap is $286.5M on the latest cached fundamentals snapshot.
What kind of company is NGNE?
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Where is NGNE stock news listed?
Cached stock news for Neurogene Inc (NGNE) is listed at https://lician.com/news/ngne. Filings: https://lician.com/sec/ngne
Not investment advice.